Hypoglycemia aggravates critical illness-induced neurocognitive dysfunction

Thomas Duning, Ingeborg van den Heuvel, Annabelle Dickmann, Thomas Volkert, Carola Wempe, Julia Reinholz, Hubertus Lohmann, Hendrik Freise, Björn Ellger, Thomas Duning, Ingeborg van den Heuvel, Annabelle Dickmann, Thomas Volkert, Carola Wempe, Julia Reinholz, Hubertus Lohmann, Hendrik Freise, Björn Ellger

Abstract

OBJECTIVE Tight glycemic control (TGC) in critically ill patients is associated with an increased risk of hypoglycemia. Whether those short episodes of hypoglycemia are associated with adverse morbidity and mortality is a matter of discussion. Using a case-control study design, we investigated whether hypoglycemia under TGC causes permanent neurocognitive dysfunction in patients surviving critical illness. RESEARCH DESIGN AND METHODS From our patient data management system, we identified adult survivors treated for >72 h in our surgical intensive care unit (ICU) between 2004 and 2007 (n = 4,635) without a history of neurocognitive dysfunction or structural brain abnormalities who experienced at least one episode of hypoglycemia during treatment (hypo group) (n = 37). For each hypo group patient, one patient stringently matched for demographic- and disease-related data were identified as a control subject. We performed a battery of neuropsychological tests investigating five areas of cognitive functioning in both groups at least 1 year after ICU discharge. Test results were compared with data from healthy control subjects and between groups. RESULTS Critical illness caused neurocognitive dysfunction in all tested domains in both groups. The dysfunction was aggravated in hypo group patients in one domain, namely that of visuospatial skills (P < 0.01). Besides hypoglycemia, both hyperglycemia (r = -0.322; P = 0.005) and fluctuations of blood glucose (r = -0.309; P = 0.008) were associated with worse test results in this domain. CONCLUSIONS Hypoglycemia was found to aggravate critical illness-induced neurocognitive dysfunction to a limited, but significant, extent; however, an impact of hyperglycemia and fluctuations of blood glucose on neurocognitive function cannot be excluded.

Figures

Figure 1
Figure 1
Flow chart of patient inclusion in the hypo group.

References

    1. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R: Intensive insulin therapy in the critically ill patients. N Engl J Med 2001;345:1359–1367
    1. Griesdale DE, de Souza RJ, van Dam RM, Heyland DK, Cook DJ, Malhotra A, Dhaliwal R, Henderson WR, Chittock DR, Finfer S, Talmor D: Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ 2009;180:821–827
    1. Vanhorebeek I, Langouche L, Van den Berghe G: Tight blood glucose control with insulin in the ICU: facts and controversies. Chest 2007;132:268–278
    1. NICE-SUGAR Study Investigators. Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hebert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ: Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009;360:1283–1297
    1. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K: the German Competence Network Sepsis (SepNet). Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008;358:125–139
    1. Vogelzang M, Loef BG, Regtien JG, van der Horst IC, van Assen H, Zijlstra F, Nijsten MW: Computer-assisted glucose control in critically ill patients. Intensive Care Med 2008;34:1421–1427
    1. Krinsley JS, Grover A: Severe hypoglycemia in critically ill patients: risk factors and outcomes. Crit Care Med 2007;35:2262–2267
    1. Vriesendorp TM, DeVries JH, van Santen S, Moeniralam HS, de Jonge E, Roos YB, Schultz MJ, Rosendaal FR, Hoekstra JB: Evaluation of short-term consequences of hypoglycemia in an intensive care unit. Crit Care Med 2006;34:2714–2718
    1. Hopkins RO, Ely EW, Jackson JC: The role of future longitudinal studies in ICU survivors: understanding determinants and pathophysiology of brain dysfunction. Curr Opin Crit Care 2007;13:497–502
    1. Lezak MD: Neuropsychological Assessment. 4th ed. Oxford, U.K., Oxford University Press, 2004.
    1. Fukui T, Lee E: Visuospatial function is a significant contributor to functional status in patients with Alzheimer's disease. Am J Alzheimers Dis Other Demen 2009;24:313–321
    1. Hamilton JM, Salmon DP, Galasko D, Raman R, Emond J, Hansen LA, Masliah E, Thal LJ: Visuospatial deficits predict rate of cognitive decline in autopsy-verified dementia with Lewy bodies. Neuropsychology 2008;22:729–737
    1. Boxer AL, Kramer JH, Du AT, Schuff N, Weiner MW, Miller BL, Rosen HJ: Focal right inferotemporal atrophy in AD with disproportionate visual constructive impairment. Neurology 2003;61:1485–1491
    1. Suh SW, Hamby AM, Swanson RA: Hypoglycemia, brain energetics, and hypoglycemic neuronal death. Glia 2007;55:1280–1286
    1. Fujioka M, Okuchi K, Hiramatsu KI, Sakaki T, Sakaguchi S, Ishii Y: Specific changes in human brain after hypoglycemic injury. Stroke 1997;28:584–587
    1. Bree AJ, Puente EC, Daphna-Iken D, Fisher SJ: Diabetes increases brain damage caused by severe hypoglycemia. Am J Physiol Endocrinol Metab 2009;297:E194–E201
    1. Auer RN: Hypoglycemic brain damage. Metab Brain Dis 2004;19:169–175
    1. McNay EC, Williamson A, McCrimmon RJ, Sherwin RS: Cognitive and neural hippocampal effects of long-term moderate recurrent hypoglycemia. Diabetes 2006;55:1088–1095
    1. Warren RE, Frier BM: Hypoglycaemia and cognitive function. Diabetes Obes Metab 2005;7:493–503
    1. Lincoln NB, Faleiro RM, Kelly C, Kirk BA, Jeffcoate WJ: Effect of long-term glycemic control on cognitive function. Diabetes Care 1996;19:656–658
    1. Robinson R, Krishnakumar A, Paulose CS: Enhanced dopamine D1 and D2 receptor gene expression in the hippocampus of hypoglycaemic and diabetic rats. Cell Mol Neurobiol 2009;29:365–372
    1. Gunther ML, Jackson JC, Ely EW: The cognitive consequences of critical illness: practical recommendations for screening and assessment. Crit Care Clin 2007;23:491–506
    1. Malone JI, Hanna S, Saporta S, Mervis RF, Park CR, Chong L, Diamond DM: Hyperglycemia not hypoglycemia alters neuronal dendrites and impairs spatial memory. Pediatr Diabetes 2008;9:531–539
    1. Suh SW, Gum ET, Hamby AM, Chan PH, Swanson RA: Hypoglycemic neuronal death is triggered by glucose reperfusion and activation of neuronal NADPH oxidase. J Clin Invest 2007;117:910–918
    1. Tanaka Y, Takata T, Satomi T, Sakurai T, Yokono K: The double-edged effect of insulin on the neuronal cell death associated with hypoglycemia on the hippocampal slice culture. Kobe J Med Sci 2008;54:E97–E107

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit